These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 34275020)
1. Design, implementation and initial findings of COVID-19 research in the Rotterdam Study: leveraging existing infrastructure for population-based investigations on an emerging disease. Licher S; Terzikhan N; Splinter MJ; Velek P; van Rooij FJA; Heemst JV; Haarman AEG; Thee EF; Geurts S; Mens MMJ; van der Schaft N; de Feijter M; Pardo LM; Kieboom BCT; Ikram MA Eur J Epidemiol; 2021 Jun; 36(6):649-654. PubMed ID: 34275020 [TBL] [Abstract][Full Text] [Related]
2. Objectives, design and main findings until 2020 from the Rotterdam Study. Ikram MA; Brusselle G; Ghanbari M; Goedegebure A; Ikram MK; Kavousi M; Kieboom BCT; Klaver CCW; de Knegt RJ; Luik AI; Nijsten TEC; Peeters RP; van Rooij FJA; Stricker BH; Uitterlinden AG; Vernooij MW; Voortman T Eur J Epidemiol; 2020 May; 35(5):483-517. PubMed ID: 32367290 [TBL] [Abstract][Full Text] [Related]
10. Case-control study of patient characteristics, knowledge of the COVID-19 disease, risk behaviour and mental state in patients visiting an emergency room with COVID-19 symptoms in the Netherlands. van der Valk JPM; Heijboer FWJ; van Middendorp H; Evers AWM; In 't Veen JCCM PLoS One; 2021; 16(4):e0249847. PubMed ID: 33909639 [TBL] [Abstract][Full Text] [Related]
11. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic. Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689 [TBL] [Abstract][Full Text] [Related]
12. Early public adherence with and support for stay-at-home COVID-19 mitigation strategies despite adverse life impact: a transnational cross-sectional survey study in the United States and Australia. Czeisler MÉ; Howard ME; Robbins R; Barger LK; Facer-Childs ER; Rajaratnam SMW; Czeisler CA BMC Public Health; 2021 Mar; 21(1):503. PubMed ID: 33722226 [TBL] [Abstract][Full Text] [Related]
13. Lifelines COVID-19 cohort: investigating COVID-19 infection and its health and societal impacts in a Dutch population-based cohort. Mc Intyre K; Lanting P; Deelen P; Wiersma HH; Vonk JM; Ori APS; Jankipersadsing SA; Warmerdam R; van Blokland I; Boulogne F; Dijkema MXL; Herkert JC; Claringbould A; Bakker O; Lopera Maya EA; Bültmann U; Zhernakova A; Reijneveld SA; Zijlstra E; Swertz MA; Brouwer S; van Ooijen R; Angelini V; Dekker LH; Sijtsma A; Scherjon SA; Wijmenga C; Dekens JAM; Mierau J; Boezen HM; Franke L BMJ Open; 2021 Mar; 11(3):e044474. PubMed ID: 33737436 [TBL] [Abstract][Full Text] [Related]
14. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?]. Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F; Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811 [TBL] [Abstract][Full Text] [Related]
15. Design and overview of the Origins of Alzheimer's Disease Across the Life course (ORACLE) study. Eur J Epidemiol; ; . PubMed ID: 33324997 [TBL] [Abstract][Full Text] [Related]